Literature DB >> 3592404

Limitations of using urea to quantify epithelial lining fluid recovered by bronchoalveolar lavage.

T W Marcy, W W Merrill, J A Rankin, H Y Reynolds.   

Abstract

The quantitation of substances in the epithelial lining fluid (ELF) of the lower respiratory tract, as obtained by bronchoalveolar lavage (BAL), is not precise because of the variable dilution of the ELF by the instilled lavage fluid. It has been reported that the absolute concentration of proteins in ELF can be determined by using the ratio of urea concentration in BAL fluid to that in serum as a method to calculate the volume of ELF recovered by BAL. Furthermore, it has been suggested that the error caused by diffusion of urea into the instilled lavage fluid can be minimized by instilling only 100 ml (5 X 20 ml) of saline rather than 300 ml (6 X 50 ml). We tested the validity of this method by collecting and individually analyzing aliquots from 2 different BAL protocols--a 100-ml (5 X 20 ml) BAL and a 300-ml (6 X 50 ml) BAL--performed in 6 healthy, nonsmoking subjects. Total protein, albumin, and urea were measured in each aliquot and in pooled fluid from each BAL procedure, and urea was measured in serum. In the 300-ml BAL, total protein and albumin concentrations tended to decrease progressively from the second to the sixth aliquots. In contrast, the urea concentration increased progressively from the first to the sixth aliquots. The concentration of albumin in ELF, calculated from the concentration of urea and albumin in each BAL aliquot, tended to decrease in each successive aliquot, becoming significant by the fourth aliquot.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3592404     DOI: 10.1164/arrd.1987.135.6.1276

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  37 in total

Review 1.  Pulmonary disposition of antimicrobial agents: methodological considerations.

Authors:  D R Baldwin; D Honeybourne; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

2.  British Thoracic Society summer meeting. 11-13 July 1990, Birmingham. Abstracts.

Authors: 
Journal:  Thorax       Date:  1990-10       Impact factor: 9.139

Review 3.  Ventilation and secretion of pulmonary surfactant.

Authors:  H Wirtz; M Schmidt
Journal:  Clin Investig       Date:  1992-01

4.  Long term smoking with age builds up excessive oxidative stress in bronchoalveolar lavage fluid.

Authors:  K Nagai; T Betsuyaku; T Kondo; Y Nasuhara; M Nishimura
Journal:  Thorax       Date:  2006-03-14       Impact factor: 9.139

5.  Lactoferrin and secretory IgA in the bronchoalveolar lavage fluid from patients with a stable asthma.

Authors:  E A van de Graaf; T A Out; A Kobesen; H M Jansen
Journal:  Lung       Date:  1991       Impact factor: 2.584

6.  Microlavage: a technique for determining the volume of epithelial lining fluid.

Authors:  D R Baldwin; R Wise; J M Andrews; D Honeybourne
Journal:  Thorax       Date:  1991-09       Impact factor: 9.139

Review 7.  Bronchoalveolar lavage as a research tool.

Authors:  E H Walters; P V Gardiner
Journal:  Thorax       Date:  1991-09       Impact factor: 9.139

8.  Effect of sex and AIDS status on the plasma and intrapulmonary pharmacokinetics of rifampicin.

Authors:  John E Conte; Jeffrey A Golden; Juliana E Kipps; Emil T Lin; Elisabeth Zurlinden
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

9.  Determination of thiocyanate in exhaled breath condensate.

Authors:  Joshua D Chandler; Hamed Horati; Douglas I Walker; Enea Pagliano; Rabindra Tirouvanziam; Mieke Veltman; Bob J Scholte; Hettie M Janssens; Young-Mi Go; Dean P Jones
Journal:  Free Radic Biol Med       Date:  2018-08-22       Impact factor: 7.376

10.  Phase I, open-label, safety and pharmacokinetic study to assess bronchopulmonary disposition of intravenous eravacycline in healthy men and women.

Authors:  Kevin P Connors; Seth T Housman; J Samuel Pope; John Russomanno; Edward Salerno; Eric Shore; Susan Redican; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2014-01-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.